Search results
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
Morningstar· 7 days agomRNA-1083 met its primary endpoints, eliciting higher immune responses against influenza virus and SARS-CoV-2 than licensed flu and & ...
Paxlovid tied to 34% lower risk of hospitalization in adolescent COVID patients
Center for Infectious Disease Research and Policy· 6 days agoNo safety concerns were reported after Paxlovid use.
A Combined Flu and COVID-19 Shot May Be Coming
Time via AOL· 7 days agoThe COVID-19 portion relies on a slightly different form of SARS-CoV-2’s spike ...
FDA reverses course, calls for vaccines for fall 2024 to target newer COVID-19 strain
Scripps News via AOL· 3 days agoThe FDA is reversing course on its COVID vaccine guidance: Rather than having a vaccine that targets...
2-in-1 shot for flu and COVID shows promise in advanced trial
Live Science via Yahoo News· 7 days agoThe new vaccine builds upon the Nobel Prize-winning technology used to develop the first...diseases,...
Another COVID vaccine? Yes, and here’s why
San Jose Mercury News· 6 days agoThis fall, prepare for the latest round of COVID vaccine Whac-a-Mole. Protection against both infection and severe illness is waning. “Effectiveness has...
FDA reverses course, calls for vaccines for fall 2024 to target newer COVID-19 strain
AOL· 3 days agoThe Food and Drug Administration provided updated guidance for COVID-19 vaccine makers, calling for...
Combined flu and Covid vaccine from Moderna shows positive trial results
PA Media: Science via Yahoo News· 7 days agoThe randomised controlled trial involved two groups of about 4,000 people each, with the first group...
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
The Sacramento Bee· 7 days agomRNA-1083 met its primary endpoints, eliciting higher immune responses against influenza virus and SARS-CoV-2 than licensed flu and & ...
FDA to vaccinemakers: Updated COVID shots should target KP.2 variant
Becker’s Hospital Review· 3 days agoThe FDA is now advising manufacturers to develop the 2024-2025 COVID-19 vaccines using the KP.2 strain for the formula, the agency announced ...